NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)

A Contract Award Notice
by NHS ENGLAND

Source: Contracts Finder
Type: Framework (Products)
Duration: 3 year
Value: £424M

Sector: HEALTH
Published: 14 May 2024
Delivery: 01 Jun 2024 to 31 May 2027
Deadline: 23 Nov 2023 13:00

Related Terms

Location

Geochart for 1 buyers and 63 suppliers

1 buyer

NHS England Runcorn

63 suppliers

Accord Barnstaple
Macure Pharma Aps Copenhagen
Neon Healthcare Hertford
Bristol Laboratories Berkhamsted
Syri Ruislip
Arcadia Pharma Swansea
Kyowa Kirin Galashiels
Waymade Basildon
DR Falk Pharma Bourne End
Lupin Healthcare Slough
Crescent Pharma Basingstoke
Derma Newcastle upon Tyne
Chiesi Manchester
Strides Pharma Watford
Galvany Pharma Stevenage
Phoenix Lab Clonee
Drugsrus Harrow
Aspen Pharmacare Paddington
MSN Laboratories Europe Letchworth
Scope Ophthalmics Crawley
Stirling Anglian Pharmaceuticals Glasgow
Eramol Sevenoaks
Aop Orphan Birmingham
Bayer Reading
Krka Slough
Thea Pharmaceuticals Newcastle under Lyme
Relonchem Widnes
Ferring Pharmaceuticals West Drayton
Torrent Pharma Crawley
JCSH Pharma Guildford
Lundbeck Watford
Takeda London
Reckitt Benckiser Slough
Strandhaven Ilford
Synchrony Stevenage
Brown & Burk Ruislip
Tillomed Laboratories Luton
Baxter Healthcare Newbury
Galen Craigavon
Reig Jofre Bideford
Necessity Supplies Northolt
Medley Pharma Liverpool
Manx Healthcare Warwick
Logixx Pharma Reading
Evolan Pharma Danderyd
Ascend Laboratories Edgware
Rivopharm London
Norgine Pharmaceuticals Harefield
Vantage Pharmaceuticals Hemel Hempstead
Cipla London
Genesis Pharmaceuticals London
Focus Pharmaceuticals London
Correvio Bielefeld
Beaumont Pharma Henley on Thames
Typharm Norwich
Oralieve Luton
Orion Pharma Reading
Recordati Pharmaceuticals Hemel Hempstead
Clydesdale Pharma Tadley
RPH Pharmaceuticals Cheadle
Tetris Pharma Marlow
PM Pharma Norwich
Uni Health Distribution Dartford

Description

Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)

Award Detail

1	Accord (Barnstaple) Value: £1
2	Macure Pharma Aps (Copenhagen) Value: £1
3	Neon Healthcare (Hertford) Value: £1
4	Bristol Laboratories (Berkhamsted) Value: £1
5	Syri (Ruislip) Value: £1
6	Arcadia Pharma (Swansea) Value: £1
7	Kyowa Kirin (Galashiels) Value: £1
8	Waymade (Basildon) Value: £1
9	DR Falk Pharma (Bourne End) Value: £1
10	Lupin Healthcare (Slough) Value: £1
11	Crescent Pharma (Basingstoke) Value: £1
12	Derma (Newcastle upon Tyne) Value: £1
13	Chiesi (Manchester) Value: £1
14	Strides Pharma (Watford) Value: £1
15	Galvany Pharma (Stevenage) Value: £1
16	Phoenix Lab (Clonee) Value: £1
17	Drugsrus (Harrow) Value: £1
18	Aspen Pharmacare (Paddington) Value: £1
19	MSN Laboratories Europe (Letchworth) Value: £1
20	Scope Ophthalmics (Crawley) Value: £1
21	Stirling Anglian Pharmaceuticals (Glasgow) Value: £1
22	Eramol (Sevenoaks) Value: £1
23	Aop Orphan (Birmingham) Value: £1
24	Bayer (Reading) Value: £1
25	Krka (Slough) Value: £1
26	Thea Pharmaceuticals (Newcastle under Lyme) Value: £1
27	Relonchem (Widnes) Value: £1
28	Ferring Pharmaceuticals (West Drayton) Value: £1
29	Torrent Pharma (Crawley) Value: £1
30	JCSH Pharma (Guildford) Value: £1
31	Lundbeck (Watford) Value: £1
32	Takeda (London) Value: £1
33	Reckitt Benckiser (Slough) Value: £1
34	Strandhaven (Ilford) Value: £1
35	Synchrony (Stevenage) Value: £1
36	Brown & Burk (Ruislip) Value: £1
37	Tillomed Laboratories (Luton) Value: £1
38	Baxter Healthcare (Newbury) Value: £1
39	Galen (Craigavon) Value: £1
40	Reig Jofre (Bideford) Value: £1
41	Necessity Supplies (Northolt) Value: £1
42	Medley Pharma (Liverpool) Value: £1
43	Manx Healthcare (Warwick) Value: £1
44	Logixx Pharma (Reading) Value: £1
45	Evolan Pharma (Danderyd) Value: £1
46	Ascend Laboratories (Edgware) Value: £1
47	Rivopharm (London) Value: £1
48	Norgine Pharmaceuticals (Harefield) Value: £1
49	Vantage Pharmaceuticals (Hemel Hempstead) Value: £1
50	Cipla (London) Value: £1
51	Genesis Pharmaceuticals (London) Value: £1
52	Focus Pharmaceuticals (London) Value: £1
53	Correvio (Bielefeld) Value: £1
54	Beaumont Pharma (Henley on Thames) Value: £1
55	Typharm (Norwich) Value: £1
56	Oralieve (Luton) Value: £1
57	Orion Pharma (Reading) Value: £1
58	Recordati Pharmaceuticals (Hemel Hempstead) Value: £1
59	Clydesdale Pharma (Tadley) Value: £1
60	RPH Pharmaceuticals (Cheadle) Value: £1
61	Tetris Pharma (Marlow) Value: £1
62	PM Pharma (Norwich) Value: £1
63	Uni Health Distribution (Dartford) Value: £1

CPV Codes

33600000 - Pharmaceutical products

Indicators

Contract is suitable for SMEs.

Other Information

Framework Agreement and Terms and Conditions - Wave 14c#2 Framework Agreement and Terms and Conditions - Wave 14c#2.pdf Transparency Award Schedule - Wave 14c Lot 1 5672_01#2 Transparency Award Schedule - Wave 14c Lot 1 5672_01#2.pdf Wave 14c Parties Appointed & SME Status#2 Wave 14c Parties Appointed & SME Status#2.xlsx Transparency Award Schedule - Wave 14c Lot 3 5672_03#2 Transparency Award Schedule - Wave 14c Lot 3 5672_03#2.pdf Transparency Award Schedule - Wave 14c Lot 2 5672_02#2 Transparency Award Schedule - Wave 14c Lot 2 5672_02#2.pdf

Reference

CF-2353700D0O000000rwimUAA
CF c3b17fe3-6ef4-4a0a-a5ef-4a4939328e53